IDEX Biometrics ASA: Approved prospectus

Reference is made to the stock exchange announcements issued by IDEX Biometrics ASA' on 29 April 2026 of a private placement of 9,696,969 new shares (the "April 2026 Private Placement Shares"), and on 29 May 2026 of a private placement of 2,500,000 new shares (the "May 2026 Private Placement Shares").

The Norwegian Financial Supervisory Authority has today (15 June 2026) approved the prospectus prepared by the Company in connection with listing of the April 2026 Private Placement Shares and the May 2026 Private Placement Shares. The prospectus is available on the Company's website: www.idexbiometrics.com/investors/
 
By reason of the approval and publication of the prospectus, the April 2026 Private Placement Shares and the May 2026 Private Placement Shares, will be transferred to the Company's ordinary ISIN and be admitted to trading on Euronext Oslo Børs.

Contacts
Anders Storbråten, Executive Chairman, Tel: [phone]
E-mail: [e-mail]

About Us
IDEX Biometrics ASA (OSE: IDEX) develops and makes fingerprint biometric cards for access control, digital identity and payment. By authenticating identity through fingerprint biometrics rather than passwords, PINs or traditional credentials, IDEX enables secure and convenient access to physical and digital services. Fingerprint matching happens directly on the card, offline and without transmitting biometric data. Certified by Visa, Mastercard, FIDO2 and EAL6+, and backed by more than 250 patents and over USD 350 million invested in R&D, IDEX serves banks, enterprises and public sector organizations directly and through channel partners worldwide.

For more information, visit www.idexbiometrics.com

This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-06-15 17:05 CEST.

Attachments
IDEX Biometrics ASA: Approved prospectus
Prospectus IDEX Biometrics June 2026 Final